Picture of Argenica Therapeutics logo

AGN Argenica Therapeutics Cashflow Statement

0.000.00%
au flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapNeutral

Annual cashflow statement for Argenica Therapeutics, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.

2020
June 30th
2021
June 30th
2022
June 30th
2023
June 30th
Period Length:12 M12 M12 M12 M
Source:ARSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinal
Changes in Working Capital000.0020.781
Other Operating Cash Flow
Cash from Operating Activities-0.059-1.05-3.36-3.3
Other Investing Cash Flow Items-0.05
Change in Net Investments
Cash from Investing Activities-0.05
Financing Cash Flow Items000
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Cash from Financing Activities0.4017.855.133.73
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash0.3426.81.770.375